These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 29310122)

  • 21. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance snapshot of Clostridium difficile infection in hospitals across Queensland detects binary toxin producing ribotype UK 244.
    Huber CA; Hall L; Foster NF; Gray M; Allen M; Richardson LJ; Robson J; Vohra R; Schlebusch S; George N; Nimmo GR; Riley TV; Paterson DL
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E279-84. PubMed ID: 25631588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance of antimicrobial susceptibilities reveals high proportions of multidrug resistance in toxigenic Clostridium difficile strains in different areas of Poland.
    Lachowicz D; Pituch H; Wultańska D; Kuijper E; Obuch-Woszczatyński P
    Anaerobe; 2020 Apr; 62():102167. PubMed ID: 32109736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hype or hypervirulence: a reflection on problematic C. difficile strains.
    Smits WK
    Virulence; 2013 Oct; 4(7):592-6. PubMed ID: 24060961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
    Nicholas A; Kim YK; Lee WK; Selasi GN; Na SH; Kwon HI; Kim YJ; Lee HS; Song KE; Shin JH; Lee JC
    PLoS One; 2017; 12(3):e0174716. PubMed ID: 28355266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-year analysis of Clostridium difficile ribotypes associated with increased severity.
    Herbert R; Hatcher J; Jauneikaite E; Gharbi M; d'Arc S; Obaray N; Rickards T; Rebec M; Blandy O; Hope R; Thomas A; Bamford K; Jepson A; Sriskandan S
    J Hosp Infect; 2019 Dec; 103(4):388-394. PubMed ID: 31220480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of pathogenicity locus (PaLoc) and tcdC genetic diversity among tcdA
    Kodori M; Ghalavand Z; Yadegar A; Eslami G; Azimirad M; Krutova M; Abadi A; Zali MR
    Anaerobe; 2020 Dec; 66():102294. PubMed ID: 33181348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains?
    Senoh M; Kato H; Fukuda T; Niikawa A; Hori Y; Hagiya H; Ito Y; Miki H; Abe Y; Furuta K; Takeuchi H; Tajima H; Tominaga H; Satomura H; Kato H; Morita S; Tanada A; Hara T; Kawada M; Sato Y; Takahashi M; Higuchi A; Nakajima T; Wakamatsu Y; Toyokawa M; Ueda A; Roberts P; Miyajima F; Shibayama K
    J Med Microbiol; 2015 Oct; 64(10):1226-1236. PubMed ID: 26238868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology of endemic Clostridioides difficile infection in Japan.
    Senoh M; Kato H
    Anaerobe; 2022 Apr; 74():102510. PubMed ID: 34990814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile.
    Goldenberg SD; French GL
    J Infect; 2011 May; 62(5):355-62. PubMed ID: 21396957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia.
    Cowardin CA; Buonomo EL; Saleh MM; Wilson MG; Burgess SL; Kuehne SA; Schwan C; Eichhoff AM; Koch-Nolte F; Lyras D; Aktories K; Minton NP; Petri WA
    Nat Microbiol; 2016 Jul; 1(8):16108. PubMed ID: 27573114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New ribotype
    Gu W; Wang W; Li W; Li N; Wang Y; Zhang W; Lu C; Tong P; Han Y; Sun X; Lu J; Wu Y; Dai J
    Emerg Microbes Infect; 2021 Dec; 10(1):687-699. PubMed ID: 33682630
    [No Abstract]   [Full Text] [Related]  

  • 34. The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates.
    Carlson PE; Walk ST; Bourgis AE; Liu MW; Kopliku F; Lo E; Young VB; Aronoff DM; Hanna PC
    Anaerobe; 2013 Dec; 24():109-16. PubMed ID: 23608205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonantimicrobial drug targets for Clostridium difficile infections.
    Darkoh C; Deaton M; DuPont HL
    Future Microbiol; 2017 Sep; 12(11):975-985. PubMed ID: 28759258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage.
    Valiente E; Dawson LF; Cairns MD; Stabler RA; Wren BW
    J Med Microbiol; 2012 Jan; 61(Pt 1):49-56. PubMed ID: 21903827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a causal relationship between trehalose consumption and Clostridioides difficile infection?
    Buckley AM; Moura IB; Wilcox MH
    Curr Opin Gastroenterol; 2021 Jan; 37(1):9-14. PubMed ID: 33105252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribotypes associated with Clostridium difficile outbreaks in Brazil display distinct surface protein profiles.
    Ferreira TG; Moura H; Barr JR; Pilotto Domingues RMC; Ferreira EO
    Anaerobe; 2017 Jun; 45():120-128. PubMed ID: 28435010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of CodY protein on metabolism, sporulation and virulence in Clostridioides difficile ribotype 027.
    Daou N; Wang Y; Levdikov VM; Nandakumar M; Livny J; Bouillaut L; Blagova E; Zhang K; Belitsky BR; Rhee K; Wilkinson AJ; Sun X; Sonenshein AL
    PLoS One; 2019; 14(1):e0206896. PubMed ID: 30699117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1.
    Akerlund T; Persson I; Unemo M; Norén T; Svenungsson B; Wullt M; Burman LG
    J Clin Microbiol; 2008 Apr; 46(4):1530-3. PubMed ID: 18287318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.